Enanta Pharmaceuticals (ENTA) Non-cash Items (2012 - 2026)

Enanta Pharmaceuticals (ENTA) has 15 years of Non-cash Items data on file, last reported at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items changed N/A year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (changed N/A YoY), and the FY2025 full-year result was $4.0 million, up 185.31% from the prior year.
• Non-cash Items for Q1 2026 stood at $4.2 million, up from $4.0 million in the prior quarter.
• Across five years, Non-cash Items topped out at $83.0 million in Q1 2022 and bottomed at $92000.0 in Q2 2025.
• The 5-year median for Non-cash Items is $4.0 million (2025), against an average of $11.6 million.
• The widest annual swing landed in 2022, when Non-cash Items soared 627.75%; it then slumped 97.8% in 2025.
• A 5-year view of Non-cash Items shows it stood at $17.6 million in 2022, then plunged by 82.84% to $3.0 million in 2023, then advanced by 14.17% to $3.5 million in 2024, then increased by 15.45% to $4.0 million in 2025, then rose by 6.36% to $4.2 million in 2026.
• The last three Non-cash Items figures came in at $4.2 million (Q1 2026), $4.0 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.

Peer Comparison